{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:31:09Z","timestamp":1792042269206,"version":"4.4.0"},"reference-count":139,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T00:00:00Z","timestamp":1709164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hypertension is a major harbinger of cardiovascular morbidity and mortality. It predisposes to higher rates of myocardial infarction, chronic kidney failure, stroke, and heart failure than most other risk factors. By 2025, the prevalence of hypertension is projected to reach 1.5 billion people. The pathophysiology of this disease is multifaceted, as it involves nitric oxide and endothelin dysregulation, reactive oxygen species, vascular smooth muscle proliferation, and vessel wall calcification, among others. With the advent of new biomolecular techniques, various studies have elucidated a gaping hole in the etiology and mechanisms of hypertension. Indeed, epigenetics, DNA methylation, histone modification, and microRNA-mediated translational silencing appear to play crucial roles in altering the molecular phenotype into a hypertensive profile. Here, we critically review the experimentally determined associations between microRNA (miRNA) molecules and hypertension pharmacotherapy. Particular attention is given to the epigenetic mechanisms underlying the physiological responses to antihypertensive drugs like candesartan, and other relevant drugs like clopidogrel, aspirin, and statins among others. Furthermore, how miRNA affects the pharmaco-epigenetics of hypertension is especially highlighted.<\/jats:p>","DOI":"10.1007\/s11010-024-04947-9","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T17:02:42Z","timestamp":1709226162000},"page":"3255-3271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The pharmaco-epigenetics of hypertension: a focus on microRNA"],"prefix":"10.1007","volume":"479","author":[{"given":"Serge","family":"Yaacoub","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Boudaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"AlKhatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Pintus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Kobeissy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3004-5675","authenticated-orcid":false,"given":"Ali H.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,29]]},"reference":[{"key":"4947_CR1","doi-asserted-by":"publisher","first-page":"115035","DOI":"10.1016\/j.bcp.2022.115035","volume":"200","author":"AA Al Attar","year":"2022","unstructured":"Al Attar AA, Fahed GI, Hoballah MM, Pedersen S, El-Yazbi AF, Nasser SA, Bitto A, Orekhov AN, Eid AH (2022) Mechanisms underlying the effects of caloric restriction on hypertension. Biochem Pharmacol 200:115035. https:\/\/doi.org\/10.1016\/j.bcp.2022.115035","journal-title":"Biochem Pharmacol"},{"key":"4947_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11906-020-1022-z","volume":"22","author":"Z Wehbe","year":"2020","unstructured":"Wehbe Z, Nasser SA, El-Yazbi A, Nasreddine S, Eid AH (2020) Estrogen and bisphenol A in hypertension. Curr Hypertens Rep 22:23. https:\/\/doi.org\/10.1007\/s11906-020-1022-z","journal-title":"Curr Hypertens Rep"},{"key":"4947_CR3","doi-asserted-by":"publisher","first-page":"106600","DOI":"10.1016\/j.vph.2019.106600","volume":"124","author":"M Fardoun","year":"2020","unstructured":"Fardoun M, Dehaini H, Shaito A, Mesmar J, El-Yazbi A, Badran A, Beydoun E, Eid AH (2020) The hypertensive potential of estrogen: an untold story. Vascul Pharmacol 124:106600. https:\/\/doi.org\/10.1016\/j.vph.2019.106600","journal-title":"Vascul Pharmacol"},{"key":"4947_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.vph.2018.09.001","volume":"111","author":"H Dehaini","year":"2018","unstructured":"Dehaini H, Fardoun M, Abou-Saleh H, El-Yazbi A, Eid AA, Eid AH (2018) Estrogen in vascular smooth muscle cells: a friend or a foe? Vascul Pharmacol 111:15\u201321. https:\/\/doi.org\/10.1016\/j.vph.2018.09.001","journal-title":"Vascul Pharmacol"},{"key":"4947_CR5","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00467-020-04579-3","volume":"36","author":"M Litwin","year":"2021","unstructured":"Litwin M, Ku\u0142aga Z (2021) Obesity, metabolic syndrome, and primary hypertension. Pediatr Nephrol 36:825\u2013837. https:\/\/doi.org\/10.1007\/s00467-020-04579-3","journal-title":"Pediatr Nephrol"},{"key":"4947_CR6","first-page":"453","volume":"96","author":"L Charles","year":"2017","unstructured":"Charles L, Triscott J, Dobbs B (2017) Secondary hypertension: discovering the underlying cause. Am Fam Physician 96:453\u2013461","journal-title":"Am Fam Physician"},{"key":"4947_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/hypertensionaha.119.14240","volume":"75","author":"FD Fuchs","year":"2020","unstructured":"Fuchs FD, Whelton PK (2020) High blood pressure and cardiovascular disease. Hypertension 75:285\u2013292. https:\/\/doi.org\/10.1161\/hypertensionaha.119.14240","journal-title":"Hypertension"},{"key":"4947_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.jash.2017.04.006","volume":"11","author":"MA Garfinkle","year":"2017","unstructured":"Garfinkle MA (2017) Salt and essential hypertension: pathophysiology and implications for treatment. J Am Soc Hypertens 11:385\u2013391. https:\/\/doi.org\/10.1016\/j.jash.2017.04.006","journal-title":"J Am Soc Hypertens"},{"key":"4947_CR9","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1113\/jphysiol.2014.271676","volume":"592","author":"JR Ivy","year":"2014","unstructured":"Ivy JR, Bailey MA (2014) Pressure natriuresis and the renal control of arterial blood pressure. J Physiol 592:3955\u20133967. https:\/\/doi.org\/10.1113\/jphysiol.2014.271676","journal-title":"J Physiol"},{"key":"4947_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11906-016-0688-8","volume":"18","author":"MS Dzeshka","year":"2016","unstructured":"Dzeshka MS, Shantsila A, Lip GY (2016) Effects of aspirin on endothelial function and hypertension. Curr Hypertens Rep 18:83. https:\/\/doi.org\/10.1007\/s11906-016-0688-8","journal-title":"Curr Hypertens Rep"},{"key":"4947_CR11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.ccc.2019.12.009","volume":"36","author":"AR Cyr","year":"2020","unstructured":"Cyr AR, Huckaby LV, Shiva SS, Zuckerbraun BS (2020) Nitric oxide and endothelial dysfunction. Crit Care Clin 36:307\u2013321. https:\/\/doi.org\/10.1016\/j.ccc.2019.12.009","journal-title":"Crit Care Clin"},{"key":"4947_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tcb.2017.10.010","volume":"28","author":"K Rohlenova","year":"2018","unstructured":"Rohlenova K, Veys K, Miranda-Santos I, De Bock K, Carmeliet P (2018) Endothelial cell metabolism in health and disease. Trends Cell Biol 28:224\u2013236. https:\/\/doi.org\/10.1016\/j.tcb.2017.10.010","journal-title":"Trends Cell Biol"},{"key":"4947_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/biom9070292","author":"AA Samaha","year":"2019","unstructured":"Samaha AA, Fawaz M, Salami A, Baydoun S, Eid AH (2019) Antihypertensive indigenous lebanese plants: ethnopharmacology and a clinical trial. Biomolecules. https:\/\/doi.org\/10.3390\/biom9070292","journal-title":"Biomolecules"},{"key":"4947_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3389\/fphar.2016.00050","volume":"7","author":"MA Anwar","year":"2016","unstructured":"Anwar MA, Al Disi SS, Eid AH (2016) Anti-hypertensive herbs and their mechanisms of action: part II. Front Pharmacol 7:50. https:\/\/doi.org\/10.3389\/fphar.2016.00050","journal-title":"Front Pharmacol"},{"key":"4947_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.3389\/fphar.2015.00323","volume":"6","author":"SS Al Disi","year":"2015","unstructured":"Al Disi SS, Anwar MA, Eid AH (2015) Anti-hypertensive herbs and their mechanisms of action: part I. Front Pharmacol 6:323. https:\/\/doi.org\/10.3389\/fphar.2015.00323","journal-title":"Front Pharmacol"},{"key":"4947_CR16","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nutres.2013.12.005","volume":"34","author":"R Shouk","year":"2014","unstructured":"Shouk R, Abdou A, Shetty K, Sarkar D, Eid AH (2014) Mechanisms underlying the antihypertensive effects of garlic bioactives. Nutr Res 34:106\u2013115. https:\/\/doi.org\/10.1016\/j.nutres.2013.12.005","journal-title":"Nutr Res"},{"key":"4947_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.coph.2019.04.014","volume":"45","author":"D Maaliki","year":"2019","unstructured":"Maaliki D, Shaito AA, Pintus G, El-Yazbi A, Eid AH (2019) Flavonoids in hypertension: a brief review of the underlying mechanisms. Curr Opin Pharmacol 45:57\u201365. https:\/\/doi.org\/10.1016\/j.coph.2019.04.014","journal-title":"Curr Opin Pharmacol"},{"key":"4947_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/5584_2016_90","volume":"956","author":"D Konukoglu","year":"2017","unstructured":"Konukoglu D, Uzun H (2017) Endothelial dysfunction and hypertension. Adv Exp Med Biol 956:511\u2013540. https:\/\/doi.org\/10.1007\/5584_2016_90","journal-title":"Adv Exp Med Biol"},{"key":"4947_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225694","author":"A Jaminon","year":"2019","unstructured":"Jaminon A, Reesink K, Kroon A, Schurgers L (2019) The role of vascular smooth muscle cells in arterial remodeling: focus on calcification-related processes. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20225694","journal-title":"Int J Mol Sci"},{"key":"4947_CR20","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1161\/circresaha.118.311342","volume":"122","author":"DK Arnett","year":"2018","unstructured":"Arnett DK, Claas SA (2018) Omics of blood pressure and hypertension. Circ Res 122:1409\u20131419. https:\/\/doi.org\/10.1161\/circresaha.118.311342","journal-title":"Circ Res"},{"key":"4947_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19113608","author":"AC Improta Caria","year":"2018","unstructured":"Improta Caria AC, Nonaka CKV, Pereira CS, Soares MBP, Macambira SG, Souza BSF (2018) Exercise training-induced changes in microRNAs: beneficial regulatory effects in hypertension, type 2 diabetes, and obesity. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19113608","journal-title":"Int J Mol Sci"},{"key":"4947_CR22","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41440-018-0071-z","volume":"41","author":"X Li","year":"2018","unstructured":"Li X, Wei Y, Wang Z (2018) microRNA-21 and hypertension. Hypertens Res 41:649\u2013661. https:\/\/doi.org\/10.1038\/s41440-018-0071-z","journal-title":"Hypertens Res"},{"key":"4947_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/ije\/dys220","volume":"42","author":"SE Alexeeff","year":"2013","unstructured":"Alexeeff SE, Baccarelli AA, Halonen J, Coull BA, Wright RO, Tarantini L, Bollati V, Sparrow D, Vokonas P, Schwartz J (2013) Association between blood pressure and DNA methylation of retrotransposons and pro-inflammatory genes. Int J Epidemiol 42:270\u2013280. https:\/\/doi.org\/10.1093\/ije\/dys220","journal-title":"Int J Epidemiol"},{"key":"4947_CR24","doi-asserted-by":"publisher","first-page":"167976","DOI":"10.1155\/2015\/167976","volume":"2015","author":"LK Wei","year":"2015","unstructured":"Wei LK, Sutherland H, Au A, Camilleri E, Haupt LM, Gan SH, Griffiths LR (2015) A potential epigenetic marker mediating serum folate and vitamin B12 levels contributes to the risk of ischemic stroke. Biomed Res Int 2015:167976. https:\/\/doi.org\/10.1155\/2015\/167976","journal-title":"Biomed Res Int"},{"key":"4947_CR25","first-page":"149","volume":"16","author":"I Smolarek","year":"2010","unstructured":"Smolarek I, Wyszko E, Barciszewska AM, Nowak S, Gawronska I, Jablecka A, Barciszewska MZ (2010) Global DNA methylation changes in blood of patients with essential hypertension. Med Sci Monit 16:149\u2013155","journal-title":"Med Sci Monit"},{"key":"4947_CR26","doi-asserted-by":"publisher","first-page":"478","DOI":"10.4161\/epi.6.4.14961","volume":"6","author":"G Riviere","year":"2011","unstructured":"Riviere G, Lienhard D, Andrieu T, Vieau D, Frey BM, Frey FJ (2011) Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation. Epigenetics 6:478\u2013489. https:\/\/doi.org\/10.4161\/epi.6.4.14961","journal-title":"Epigenetics"},{"key":"4947_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.atherosclerosis.2007.11.029","volume":"199","author":"S Friso","year":"2008","unstructured":"Friso S, Pizzolo F, Choi SW, Guarini P, Castagna A, Ravagnani V, Carletto A, Pattini P, Corrocher R, Olivieri O (2008) Epigenetic control of 11 beta-hydroxysteroid dehydrogenase 2 gene promoter is related to human hypertension. Atherosclerosis 199:323\u2013327. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.11.029","journal-title":"Atherosclerosis"},{"key":"4947_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11906-010-0173-8","volume":"13","author":"RM Millis","year":"2011","unstructured":"Millis RM (2011) Epigenetics and hypertension. Curr Hypertens Rep 13:21\u201328. https:\/\/doi.org\/10.1007\/s11906-010-0173-8","journal-title":"Curr Hypertens Rep"},{"key":"4947_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.lfs.2014.08.003","volume":"129","author":"L Raftopoulos","year":"2015","unstructured":"Raftopoulos L, Katsi V, Makris T, Tousoulis D, Stefanadis C, Kallikazaros I (2015) Epigenetics, the missing link in hypertension. Life Sci 129:22\u201326. https:\/\/doi.org\/10.1016\/j.lfs.2014.08.003","journal-title":"Life Sci"},{"key":"4947_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium EP (2012) An integrated encyclopedia of DNA elements in the human genome. Nature 489:57\u201374. https:\/\/doi.org\/10.1038\/nature11247","journal-title":"Nature"},{"key":"4947_CR31","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.047662","author":"M Hill","year":"2021","unstructured":"Hill M, Tran N (2021) miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. https:\/\/doi.org\/10.1242\/dmm.047662","journal-title":"Dis Model Mech"},{"key":"4947_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.phrs.2017.04.011","volume":"121","author":"S Socco","year":"2017","unstructured":"Socco S, Bovee RC, Palczewski MB, Hickok JR, Thomas DD (2017) Epigenetics: the third pillar of nitric oxide signaling. Pharmacol Res 121:52\u201358. https:\/\/doi.org\/10.1016\/j.phrs.2017.04.011","journal-title":"Pharmacol Res"},{"key":"4947_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20246249","author":"M Correia de Sousa","year":"2019","unstructured":"Correia de Sousa M, Gjorgjieva M, Dolicka D, Sobolewski C, Foti M (2019) Deciphering miRNAs\u2019 action through miRNA editing. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20246249","journal-title":"Int J Mol Sci"},{"key":"4947_CR34","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/s41440-020-0492-3","volume":"43","author":"VC Biancardi","year":"2020","unstructured":"Biancardi VC, Sharma NM (2020) Connecting sympathetic and renin-angiotensin system overdrive in neurogenic hypertension through miRNA-181a. Hypertens Res 43:1309\u20131310. https:\/\/doi.org\/10.1038\/s41440-020-0492-3","journal-title":"Hypertens Res"},{"key":"4947_CR35","first-page":"397","volume":"39","author":"L Duan","year":"2014","unstructured":"Duan L, Xiong XJ, Wang J (2014) MicroRNA and hypertension. Zhongguo Zhong Yao Za Zhi 39:397\u2013401","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"4947_CR36","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/jch.13704","volume":"21","author":"G Ozkan","year":"2019","unstructured":"Ozkan G, Ulusoy S, Geyik E, Erdem Y (2019) Down-regulation of miRNA 145 and up-regulation of miRNA 4516 may be associated with primary hypertension. J Clin Hypertens (Greenwich) 21:1724\u20131731. https:\/\/doi.org\/10.1111\/jch.13704","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"4947_CR37","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s13577-020-00333-x","volume":"33","author":"L Zhang","year":"2020","unstructured":"Zhang L, Yang F, Yan Q (2020) Candesartan ameliorates vascular smooth muscle cell proliferation via regulating miR-301b\/STAT3 axis. Hum Cell 33:528\u2013536. https:\/\/doi.org\/10.1007\/s13577-020-00333-x","journal-title":"Hum Cell"},{"key":"4947_CR38","doi-asserted-by":"publisher","first-page":"168148","DOI":"10.1016\/j.scitotenv.2023.168148","volume":"907","author":"WZ Li","year":"2024","unstructured":"Li WZ, Zhang HZ, Chen ZM, Tao YQ, Huang XZ, Chen WH, Wang DM (2024) MiRNA-92a-3p mediated the association between occupational noise exposure and blood pressure among Chinese adults. Sci Total Environ 907:168148. https:\/\/doi.org\/10.1016\/j.scitotenv.2023.168148","journal-title":"Sci Total Environ"},{"key":"4947_CR39","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-3-319-22671-2_11","volume":"888","author":"FZ Marques","year":"2015","unstructured":"Marques FZ, Charchar FJ (2015) microRNAs in essential hypertension and blood pressure regulation. Adv Exp Med Biol 888:215\u2013235. https:\/\/doi.org\/10.1007\/978-3-319-22671-2_11","journal-title":"Adv Exp Med Biol"},{"key":"4947_CR40","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/jhh.2014.99","volume":"29","author":"FZ Marques","year":"2015","unstructured":"Marques FZ, Booth SA, Charchar FJ (2015) The emerging role of non-coding RNA in essential hypertension and blood pressure regulation. J Hum Hypertens 29:459\u2013467. https:\/\/doi.org\/10.1038\/jhh.2014.99","journal-title":"J Hum Hypertens"},{"key":"4947_CR41","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1038\/emm.2015.45","volume":"47","author":"JD Kim","year":"2015","unstructured":"Kim JD, Lee A, Choi J, Park Y, Kang H, Chang W, Lee MS, Kim J (2015) Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension. Exp Mol Med 47:e175. https:\/\/doi.org\/10.1038\/emm.2015.45","journal-title":"Exp Mol Med"},{"key":"4947_CR42","doi-asserted-by":"publisher","first-page":"13434","DOI":"10.3390\/ijms241713434","volume":"24","author":"A Wojtasinska","year":"2023","unstructured":"Wojtasinska A, Frak W, Lisinska W, Sapeda N, Mlynarska E, Rysz J, Franczyk B (2023) Novel insights into the molecular mechanisms of atherosclerosis. Int J Mol Sci 24:13434. https:\/\/doi.org\/10.3390\/ijms241713434","journal-title":"Int J Mol Sci"},{"key":"4947_CR43","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1002\/jcp.31019","volume":"238","author":"D Aboukhater","year":"2023","unstructured":"Aboukhater D, Morad B, Nasrallah N, Nasser SA, Sahebkar A, Kobeissy F, Boudaka A, Eid AH (2023) Inflammation and hypertension: underlying mechanisms and emerging understandings. J Cell Physiol 238:1148\u20131159. https:\/\/doi.org\/10.1002\/jcp.31019","journal-title":"J Cell Physiol"},{"key":"4947_CR44","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1002\/jcp.31071","volume":"238","author":"K Aramouni","year":"2023","unstructured":"Aramouni K, Assaf R, Shaito A, Fardoun M, Al-Asmakh M, Sahebkar A, Eid AH (2023) Biochemical and cellular basis of oxidative stress: Implications for disease onset. J Cell Physiol 238:1951\u20131963. https:\/\/doi.org\/10.1002\/jcp.31071","journal-title":"J Cell Physiol"},{"key":"4947_CR45","doi-asserted-by":"publisher","first-page":"1285754","DOI":"10.3389\/fphar.2023.1285754","volume":"14","author":"K Aramouni","year":"2023","unstructured":"Aramouni K, Assaf RK, Azar M, Jabbour K, Shaito A, Sahebkar A, Eid AA, Rizzo M, Eid AH (2023) Infection with Helicobacter pylori may predispose to atherosclerosis: role of inflammation and thickening of intima-media of carotid arteries. Front Pharmacol 14:1285754. https:\/\/doi.org\/10.3389\/fphar.2023.1285754","journal-title":"Front Pharmacol"},{"key":"4947_CR46","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.2174\/138161282718210531101018","volume":"27","author":"AH Eid","year":"2021","unstructured":"Eid AH, Parenti A (2021) Vascular inflammation: players and modulators. Curr Pharm Des 27:2097\u20132098. https:\/\/doi.org\/10.2174\/138161282718210531101018","journal-title":"Curr Pharm Des"},{"key":"4947_CR47","doi-asserted-by":"publisher","first-page":"4134093","DOI":"10.1155\/2017\/4134093","volume":"2017","author":"M Fardoun","year":"2017","unstructured":"Fardoun M, Al-Shehabi T, El-Yazbi A, Issa K, Zouein F, Maaliki D, Iratni R, Eid AH (2017) Ziziphus nummularia inhibits inflammation-induced atherogenic phenotype of human aortic smooth muscle cells. Oxid Med Cell Longev 2017:4134093. https:\/\/doi.org\/10.1155\/2017\/4134093","journal-title":"Oxid Med Cell Longev"},{"key":"4947_CR48","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1042\/CS20200356","volume":"134","author":"MM Fardoun","year":"2020","unstructured":"Fardoun MM, Maaliki D, Halabi N, Iratni R, Bitto A, Baydoun E, Eid AH (2020) Flavonoids in adipose tissue inflammation and atherosclerosis: one arrow, two targets. Clin Sci (Lond) 134:1403\u20131432. https:\/\/doi.org\/10.1042\/CS20200356","journal-title":"Clin Sci (Lond)"},{"key":"4947_CR49","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.2174\/1381612827666210122142811","volume":"27","author":"SA Nasser","year":"2021","unstructured":"Nasser SA, Afify EA, Kobeissy F, Hamam B, Eid AH, El-Mas MM (2021) Inflammatory basis of atherosclerosis: modulation by sex hormones. Curr Pharm Des 27:2099\u20132111. https:\/\/doi.org\/10.2174\/1381612827666210122142811","journal-title":"Curr Pharm Des"},{"key":"4947_CR50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.31083\/j.fbl2703105","volume":"27","author":"A Shaito","year":"2022","unstructured":"Shaito A, Aramouni K, Assaf R, Parenti A, Orekhov A, Yazbi AE, Pintus G, Eid AH (2022) Oxidative stress-induced endothelial dysfunction in cardiovascular diseases. Front Biosci (Landmark Ed) 27:105. https:\/\/doi.org\/10.31083\/j.fbl2703105","journal-title":"Front Biosci (Landmark Ed)"},{"key":"4947_CR51","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1007\/s00018-023-04793-w","volume":"80","author":"G Wang","year":"2023","unstructured":"Wang G, Luo YL, Gao XJ, Liang Y, Yang FF, Wu JB, Fang D, Luo M (2023) MicroRNA regulation of phenotypic transformations in vascular smooth muscle: relevance to vascular remodeling. Cell Mol Life Sci 80:144. https:\/\/doi.org\/10.1007\/s00018-023-04793-w","journal-title":"Cell Mol Life Sci"},{"key":"4947_CR52","doi-asserted-by":"publisher","first-page":"105361","DOI":"10.1016\/j.micpath.2021.105361","volume":"162","author":"F Ali","year":"2022","unstructured":"Ali F, Shen AL, Islam W, Saleem MZ, Muthu R, Xie QR, Wu MZ, Cheng Y, Chu JF, Lin W, Peng J (2022) Role of MicroRNAs and their corresponding ACE2\/Apelin signaling pathways in hypertension. Microb Pathog 162:105361. https:\/\/doi.org\/10.1016\/j.micpath.2021.105361","journal-title":"Microb Pathog"},{"key":"4947_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094762","author":"M Adamcova","year":"2021","unstructured":"Adamcova M, Kawano I, Simko F (2021) The impact of microRNAs in renin-angiotensin-system-induced cardiac remodelling. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22094762","journal-title":"Int J Mol Sci"},{"key":"4947_CR54","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","volume":"116","author":"L Te Riet","year":"2015","unstructured":"Te Riet L, van Esch JH, Roks AJ, van den Meiracker AH, Danser AH (2015) Hypertension: renin-angiotensin-aldosterone system alterations. Circ Res 116:960\u2013975. https:\/\/doi.org\/10.1161\/CIRCRESAHA.116.303587","journal-title":"Circ Res"},{"key":"4947_CR55","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.biopha.2017.07.091","volume":"94","author":"S Patel","year":"2017","unstructured":"Patel S, Rauf A, Khan H, Abu-Izneid T (2017) Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed Pharmacother 94:317\u2013325. https:\/\/doi.org\/10.1016\/j.biopha.2017.07.091","journal-title":"Biomed Pharmacother"},{"key":"4947_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22037\/aaem.v10i1.1704","volume":"10","author":"M Mohammadi","year":"2022","unstructured":"Mohammadi M, Mohamadi M, Moradi A, Ramawad HA, Gharin P, Azizi Y, Yousefifard M (2022) Apelin as a candidate for hypertension management; a review and meta on animal studies. Archiv Acad Emerg Med 10:1\u201313. https:\/\/doi.org\/10.22037\/aaem.v10i1.1704","journal-title":"Archiv Acad Emerg Med"},{"key":"4947_CR57","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2020.11644","author":"Q He","year":"2021","unstructured":"He Q, Wang Y, Yang H, Wang J, Zhang J, Liu D (2021) Apelin-36 protects against lipopolysaccharide-induced acute lung injury by inhibiting the ASK1\/MAPK signaling pathway. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2020.11644","journal-title":"Mol Med Rep"},{"key":"4947_CR58","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1161\/HYPERTENSIONAHA.113.01701","volume":"62","author":"KL Jackson","year":"2013","unstructured":"Jackson KL, Marques FZ, Watson AM, Palma-Rigo K, Nguyen-Huu TP, Morris BJ, Charchar FJ, Davern PJ, Head GA (2013) A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH\/2J genetically hypertensive mice. Hypertension 62:775\u2013781. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.113.01701","journal-title":"Hypertension"},{"key":"4947_CR59","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41440-020-0453-x","volume":"43","author":"KL Jackson","year":"2020","unstructured":"Jackson KL, Gueguen C, Lim K, Eikelis N, Stevenson ER, Charchar FJ, Lambert GW, Burke SL, Paterson MR, Marques FZ, Head GA (2020) Neural suppression of miRNA-181a in the kidney elevates renin expression and exacerbates hypertension in Schlager mice. Hypertens Res 43:1152\u20131164. https:\/\/doi.org\/10.1038\/s41440-020-0453-x","journal-title":"Hypertens Res"},{"key":"4947_CR60","doi-asserted-by":"publisher","first-page":"11190","DOI":"10.3390\/ijms140611190","volume":"14","author":"TV Eskildsen","year":"2013","unstructured":"Eskildsen TV, Jeppesen PL, Schneider M, Nossent AY, Sandberg MB, Hansen PB, Jensen CH, Hansen ML, Marcussen N, Rasmussen LM, Bie P, Andersen DC, Sheikh SP (2013) Angiotensin II regulates microRNA-132\/-212 in hypertensive rats and humans. Int J Mol Sci 14:11190\u201311207. https:\/\/doi.org\/10.3390\/ijms140611190","journal-title":"Int J Mol Sci"},{"key":"4947_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-021-00597-2","author":"N Eikelis","year":"2021","unstructured":"Eikelis N, Dixon JB, Lambert EA, Hanin G, Tzur Y, Greenberg DS, Soreq H, Marques FZ, Fahey MT, Head GA, Schlaich MP, Lambert GW (2021) MicroRNA-132 may be associated with blood pressure and liver steatosis-preliminary observations in obese individuals. J Hum Hypertens. https:\/\/doi.org\/10.1038\/s41371-021-00597-2","journal-title":"J Hum Hypertens"},{"key":"4947_CR62","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.yjmcc.2014.06.008","volume":"75","author":"JR Kemp","year":"2014","unstructured":"Kemp JR, Unal H, Desnoyer R, Yue H, Bhatnagar A, Karnik SS (2014) Angiotensin II-regulated microRNA 483\u20133p directly targets multiple components of the renin-angiotensin system. J Mol Cell Cardiol 75:25\u201339. https:\/\/doi.org\/10.1016\/j.yjmcc.2014.06.008","journal-title":"J Mol Cell Cardiol"},{"key":"4947_CR63","doi-asserted-by":"publisher","first-page":"e11303","DOI":"10.15252\/emmm.201911303","volume":"12","author":"J Zhang","year":"2020","unstructured":"Zhang J, He Y, Yan X, Chen S, He M, Lei Y, Zhang J, Gongol B, Gu M, Miao Y, Bai L, Cui X, Wang X, Zhang Y, Fan F, Li Z, Shen Y, Chou CH, Huang HD, Malhotra A, Rabinovitch M, Jing ZC, Shyy JY (2020) MicroRNA-483 amelioration of experimental pulmonary hypertension. EMBO Mol Med 12:e11303. https:\/\/doi.org\/10.15252\/emmm.201911303","journal-title":"EMBO Mol Med"},{"key":"4947_CR64","doi-asserted-by":"publisher","first-page":"3698219","DOI":"10.1155\/2022\/3698219","volume":"2022","author":"F Shang","year":"2022","unstructured":"Shang F, Guo X, Chen Y, Wang C, Gao J, Wen E, Lai B, Bai L (2022) Endothelial microRNA-483-3p is hypertension-protective. Oxid Med Cell Longev 2022:3698219. https:\/\/doi.org\/10.1155\/2022\/3698219","journal-title":"Oxid Med Cell Longev"},{"key":"4947_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1177\/1470320313503693","volume":"15","author":"LX Yang","year":"2014","unstructured":"Yang LX, Liu G, Zhu GF, Liu H, Guo RW, Qi F, Zou JH (2014) MicroRNA-155 inhibits angiotensin II-induced vascular smooth muscle cell proliferation. J Renin Angiotensin Aldosterone Syst 15:109\u2013116. https:\/\/doi.org\/10.1177\/1470320313503693","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"4947_CR66","doi-asserted-by":"publisher","first-page":"l2381","DOI":"10.1136\/bmj.l2381","volume":"366","author":"GJ Burton","year":"2019","unstructured":"Burton GJ, Redman CW, Roberts JM, Moffett A (2019) Pre-eclampsia: pathophysiology and clinical implications. BMJ 366:l2381. https:\/\/doi.org\/10.1136\/bmj.l2381","journal-title":"BMJ"},{"key":"4947_CR67","doi-asserted-by":"publisher","first-page":"114703","DOI":"10.1016\/j.bcp.2021.114703","volume":"192","author":"AM Wedn","year":"2021","unstructured":"Wedn AM, El-Bassossy HM, Eid AH, El-Mas MM (2021) Modulation of preeclampsia by the cholinergic anti-inflammatory pathway: therapeutic perspectives. Biochem Pharmacol 192:114703. https:\/\/doi.org\/10.1016\/j.bcp.2021.114703","journal-title":"Biochem Pharmacol"},{"key":"4947_CR68","doi-asserted-by":"publisher","first-page":"e12511","DOI":"10.1111\/micc.12511","volume":"26","author":"D Maaliki","year":"2019","unstructured":"Maaliki D, Issa K, Al Shehabi T, El-Yazbi A, Eid AH (2019) The role of alpha2-adrenergic receptors in hypertensive preeclampsia: a hypothesis. Microcirculation 26:e12511. https:\/\/doi.org\/10.1111\/micc.12511","journal-title":"Microcirculation"},{"key":"4947_CR69","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1002\/jcp.27291","volume":"234","author":"Y Lv","year":"2019","unstructured":"Lv Y, Lu C, Ji X, Miao Z, Long W, Ding H, Lv M (2019) Roles of microRNAs in preeclampsia. J Cell Physiol 234:1052\u20131061. https:\/\/doi.org\/10.1002\/jcp.27291","journal-title":"J Cell Physiol"},{"key":"4947_CR70","first-page":"94","volume":"7","author":"M Koushki","year":"2018","unstructured":"Koushki M, Amiri Dash Atan N, Omidi-Ardali H, Rezaei Tavirani M (2018) Assessment of correlation between miR-210 expression and pre-eclampsia risk: a meta-analysis. Rep Biochem Mol Biol 7:94\u2013101","journal-title":"Rep Biochem Mol Biol"},{"key":"4947_CR71","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.preghy.2017.09.002","volume":"10","author":"O Biro","year":"2017","unstructured":"Biro O, Alasztics B, Molvarec A, Joo J, Nagy B, Rigo J Jr (2017) Various levels of circulating exosomal total-miRNA and miR-210 hypoxamiR in different forms of pregnancy hypertension. Pregnancy Hypertens 10:207\u2013212. https:\/\/doi.org\/10.1016\/j.preghy.2017.09.002","journal-title":"Pregnancy Hypertens"},{"key":"4947_CR72","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s12276-020-0478-x","volume":"52","author":"JH Kim","year":"2020","unstructured":"Kim JH, Kim JY, Park M, Kim S, Kim T, Kim J, Choi S, Park W, Hwang JY, Choe J, Ha KS, Won MH, Ryoo S, Kwon YG, Kim YM (2020) NF-\u03baB-dependent miR-31\/155 biogenesis is essential for TNF-\u03b1-induced impairment of endothelial progenitor cell function. Exp Mol Med 52:1298\u20131309. https:\/\/doi.org\/10.1038\/s12276-020-0478-x","journal-title":"Exp Mol Med"},{"key":"4947_CR73","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41371-020-0381-x","volume":"35","author":"L Lv","year":"2021","unstructured":"Lv L, Shen J, Xu J, Wu X, Zeng C, Lin L, Mao W, Wei T (2021) MiR-124-3p reduces angiotensin II-dependent hypertension by down-regulating EGR1. J Hum Hypertens 35:696\u2013708. https:\/\/doi.org\/10.1038\/s41371-020-0381-x","journal-title":"J Hum Hypertens"},{"key":"4947_CR74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1183\/16000617.0096-2015","volume":"25","author":"A Vonk Noordegraaf","year":"2016","unstructured":"Vonk Noordegraaf A, Groeneveldt JA, Bogaard HJ (2016) Pulmonary hypertension. Eur Respir Rev 25:4\u201311. https:\/\/doi.org\/10.1183\/16000617.0096-2015","journal-title":"Eur Respir Rev"},{"key":"4947_CR75","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.mayocp.2020.04.039","volume":"95","author":"SA Mandras","year":"2020","unstructured":"Mandras SA, Mehta HS, Vaidya A (2020) Pulmonary hypertension: a brief guide for clinicians. Mayo Clin Proc 95:1978\u20131988. https:\/\/doi.org\/10.1016\/j.mayocp.2020.04.039","journal-title":"Mayo Clin Proc"},{"key":"4947_CR76","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1165\/rcmb.2014-0166TR","volume":"52","author":"G Zhou","year":"2015","unstructured":"Zhou G, Chen T, Raj JU (2015) MicroRNAs in pulmonary arterial hypertension. Am J Respir Cell Mol Biol 52:139\u2013151. https:\/\/doi.org\/10.1165\/rcmb.2014-0166TR","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4947_CR77","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/978-3-319-22671-2_12","volume":"888","author":"O Boucherat","year":"2015","unstructured":"Boucherat O, Potus F, Bonnet S (2015) microRNA and pulmonary hypertension. Adv Exp Med Biol 888:237\u2013252. https:\/\/doi.org\/10.1007\/978-3-319-22671-2_12","journal-title":"Adv Exp Med Biol"},{"key":"4947_CR78","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2174\/15701611113119990010","volume":"13","author":"J Meloche","year":"2015","unstructured":"Meloche J, Paulin R, Provencher S, Bonnet S (2015) Therapeutic potential of microRNA modulation in pulmonary arterial hypertension. Curr Vasc Pharmacol 13:331\u2013340. https:\/\/doi.org\/10.2174\/15701611113119990010","journal-title":"Curr Vasc Pharmacol"},{"key":"4947_CR79","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1080\/0886022x.2021.1915800","volume":"43","author":"SP Kara","year":"2021","unstructured":"Kara SP, Ozkan G, Y\u0131lmaz A, Bayrak\u00e7\u0131 N, G\u00fczel S, Geyik E (2021) MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone. Ren Fail 43:676\u2013683. https:\/\/doi.org\/10.1080\/0886022x.2021.1915800","journal-title":"Ren Fail"},{"key":"4947_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083852","author":"H Zhang","year":"2021","unstructured":"Zhang H, Laux A, Stenmark KR, Hu CJ (2021) Mechanisms contributing to the dysregulation of miRNA-124 in pulmonary hypertension. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22083852","journal-title":"Int J Mol Sci"},{"key":"4947_CR81","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1161\/circulationaha.117.028069","volume":"136","author":"H Zhang","year":"2017","unstructured":"Zhang H, Wang D, Li M, Plecit\u00e1-Hlavat\u00e1 L, D\u2019Alessandro A, Tauber J, Riddle S, Kumar S, Flockton A, McKeon BA, Frid MG, Reisz JA, Caruso P, El Kasmi KC, Je\u017eek P, Morrell NW, Hu CJ, Stenmark KR (2017) Metabolic and proliferative state of vascular adventitial fibroblasts in pulmonary hypertension is regulated through a microRNA-124\/PTBP1 (polypyrimidine tract binding protein 1)\/pyruvate kinase muscle axis. Circulation 136:2468\u20132485. https:\/\/doi.org\/10.1161\/circulationaha.117.028069","journal-title":"Circulation"},{"key":"4947_CR82","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/j.biopha.2018.11.058","volume":"109","author":"Y Li","year":"2019","unstructured":"Li Y, Ren W, Wang X, Yu X, Cui L, Li X, Zhang X, Shi B (2019) MicroRNA-150 relieves vascular remodeling and fibrosis in hypoxia-induced pulmonary hypertension. Biomed Pharmacother 109:1740\u20131749. https:\/\/doi.org\/10.1016\/j.biopha.2018.11.058","journal-title":"Biomed Pharmacother"},{"key":"4947_CR83","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.omtn.2020.10.042","volume":"23","author":"G Russomanno","year":"2021","unstructured":"Russomanno G, Jo KB, Abdul-Salam VB, Morgan C, Endruschat J, Schaeper U, Osman AH, Alzaydi MM, Wilkins MR, Wojciak-Stothard B (2021) miR-150-PTPMT1-cardiolipin signaling in pulmonary arterial hypertension. Mol Ther Nucleic Acids 23:142\u2013153. https:\/\/doi.org\/10.1016\/j.omtn.2020.10.042","journal-title":"Mol Ther Nucleic Acids"},{"key":"4947_CR84","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2217\/epi-2016-0089","volume":"8","author":"AM Rothman","year":"2016","unstructured":"Rothman AM, Rowlands DJ, Lawrie A (2016) miRNA-140-5p: new avenue for pulmonary arterial hypertension drug development? Epigenomics 8:1311\u20131313. https:\/\/doi.org\/10.2217\/epi-2016-0089","journal-title":"Epigenomics"},{"key":"4947_CR85","doi-asserted-by":"publisher","first-page":"2979","DOI":"10.1007\/s00018-017-2510-4","volume":"74","author":"M Orriols","year":"2017","unstructured":"Orriols M, Gomez-Puerto MC, Ten Dijke P (2017) BMP type II receptor as a therapeutic target in pulmonary arterial hypertension. Cell Mol Life Sci 74:2979\u20132995. https:\/\/doi.org\/10.1007\/s00018-017-2510-4","journal-title":"Cell Mol Life Sci"},{"key":"4947_CR86","doi-asserted-by":"publisher","first-page":"e451","DOI":"10.1097\/mjt.0000000000000224","volume":"23","author":"P Reddy","year":"2016","unstructured":"Reddy P, Dupree L (2016) Approach to antihypertensive therapy. Am J Ther 23:e451\u2013e473. https:\/\/doi.org\/10.1097\/mjt.0000000000000224","journal-title":"Am J Ther"},{"key":"4947_CR87","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.phrs.2017.09.011","volume":"125","author":"C Tsioufis","year":"2017","unstructured":"Tsioufis C, Thomopoulos C (2017) Combination drug treatment in hypertension. Pharmacol Res 125:266\u2013271. https:\/\/doi.org\/10.1016\/j.phrs.2017.09.011","journal-title":"Pharmacol Res"},{"key":"4947_CR88","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.tcm.2019.08.005","volume":"30","author":"M Paseban","year":"2020","unstructured":"Paseban M, Marjaneh RM, Banach M, Riahi MM, Bo S, Sahebkar A (2020) Modulation of microRNAs by aspirin in cardiovascular disease. Trends Cardiovasc Med 30:249\u2013254. https:\/\/doi.org\/10.1016\/j.tcm.2019.08.005","journal-title":"Trends Cardiovasc Med"},{"key":"4947_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19041174","author":"S Stoll","year":"2018","unstructured":"Stoll S, Wang C, Qiu H (2018) DNA methylation and histone modification in hypertension. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19041174","journal-title":"Int J Mol Sci"},{"key":"4947_CR90","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/09537104.2019.1696455","volume":"31","author":"WL Zhou","year":"2020","unstructured":"Zhou WL, Mo ZZ, Xiao FY, Dai W, Wang G, Zhou G, Zhang W, Chen BL (2020) microRNA-605 rs2043556 polymorphisms affect clopidogrel therapy through modulation of CYP2B6 and P2RY12 in acute coronary syndrome patients. Platelets 31:897\u2013905. https:\/\/doi.org\/10.1080\/09537104.2019.1696455","journal-title":"Platelets"},{"key":"4947_CR91","doi-asserted-by":"publisher","first-page":"36","DOI":"10.5152\/TurkThoracJ.2018.18014","volume":"20","author":"I Yilmaz","year":"2019","unstructured":"Yilmaz I (2019) Angiotensin-converting enzyme inhibitors induce cough. Turk Thorac J 20:36\u201342. https:\/\/doi.org\/10.5152\/TurkThoracJ.2018.18014","journal-title":"Turk Thorac J"},{"key":"4947_CR92","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/1470320310391503","volume":"12","author":"Z Zhenfeng","year":"2011","unstructured":"Zhenfeng Z, Huilan S, Junya J, Dong L, Shan L (2011) A systematic review and meta-analysis of candesartan and losartan in the management of essential hypertension. J Renin Angiotensin Aldosterone Syst 12:365\u2013374. https:\/\/doi.org\/10.1177\/1470320310391503","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"4947_CR93","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmj.1.5897.60","volume":"1","author":"GS Stokes","year":"1974","unstructured":"Stokes GS, Weber MA, Thornell IR (1974) Beta-blockers and plasma renin activity in hypertension. Br Med J 1:60\u201362. https:\/\/doi.org\/10.1136\/bmj.1.5897.60","journal-title":"Br Med J"},{"key":"4947_CR94","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ejps.2019.02.013","volume":"131","author":"MH Solayman","year":"2019","unstructured":"Solayman MH, Langaee TY, Gong Y, Shahin MH, Turner ST, Chapman AB, Gums JG, Boerwinkle E, Beitelshees AL, El-Hamamsy M, El-Wakeel L, Cooper-DeHoff RM, Badary OA, Johnson JA (2019) Effect of plasma MicroRNA on antihypertensive response to beta blockers in the pharmacogenomic evaluation of antihypertensive responses (PEAR) studies. Eur J Pharm Sci 131:93\u201398. https:\/\/doi.org\/10.1016\/j.ejps.2019.02.013","journal-title":"Eur J Pharm Sci"},{"key":"4947_CR95","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.jacc.2017.04.001","volume":"69","author":"D Kotecha","year":"2017","unstructured":"Kotecha D, Flather MD, Altman DG, Holmes J, Rosano G, Wikstrand J, Packer M, Coats AJS, Manzano L, B\u00f6hm M, van Veldhuisen DJ, Andersson B, Wedel H, von Lueder TG, Rigby AS, Hjalmarson \u00c5, Kjekshus J, Cleland JGF (2017) Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure. J Am Coll Cardiol 69:2885\u20132896. https:\/\/doi.org\/10.1016\/j.jacc.2017.04.001","journal-title":"J Am Coll Cardiol"},{"key":"4947_CR96","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.yjmcc.2013.10.003","volume":"65","author":"S Ling","year":"2013","unstructured":"Ling S, Nanhwan M, Qian J, Kodakandla M, Castillo AC, Thomas B, Liu H, Ye Y (2013) Modulation of microRNAs in hypertension-induced arterial remodeling through the \u03b21 and \u03b23-adrenoreceptor pathways. J Mol Cell Cardiol 65:127\u2013136. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.10.003","journal-title":"J Mol Cell Cardiol"},{"key":"4947_CR97","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41440-021-00630-4","volume":"44","author":"JS Del Mauro","year":"2021","unstructured":"Del Mauro JS, Prince PD, Santander Plantamura Y, Allo MA, Parola L, Fernandez Machulsky N, Morett\u00f3n MA, Bin EP, Gonz\u00e1lez GE, Bertera FM, Carranza A, Berg G, Taira CA, Donato M, Chiappetta DA, Polizio AH, H\u00f6cht C (2021) Nebivolol is more effective than atenolol for blood pressure variability attenuation and target organ damage prevention in L-NAME hypertensive rats. Hypertens Res 44:791\u2013802. https:\/\/doi.org\/10.1038\/s41440-021-00630-4","journal-title":"Hypertens Res"},{"key":"4947_CR98","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1161\/HYPERTENSIONAHA.111.00892","volume":"61","author":"H Ye","year":"2013","unstructured":"Ye H, Ling S, Castillo AC, Thomas B, Long B, Qian J, Perez-Polo JR, Ye Y, Chen X, Birnbaum Y (2013) Nebivolol induces distinct changes in profibrosis microRNA expression compared with atenolol, in salt-sensitive hypertensive rats. Hypertension 61:1008\u20131013. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.00892","journal-title":"Hypertension"},{"key":"4947_CR99","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1016\/j.dsx.2019.06.009","volume":"13","author":"MJ Shahwan","year":"2019","unstructured":"Shahwan MJ, Jairoun AA, Farajallah A, Shanabli S (2019) Prevalence of dyslipidemia and factors affecting lipid profile in patients with type 2 diabetes. Diabetes Metab Syndr 13:2387\u20132392. https:\/\/doi.org\/10.1016\/j.dsx.2019.06.009","journal-title":"Diabetes Metab Syndr"},{"issue":"Suppl 1","key":"4947_CR100","doi-asserted-by":"publisher","first-page":"S178","DOI":"10.1016\/j.jcjd.2017.10.019","volume":"42","author":"GBJ Mancini","year":"2018","unstructured":"Diabetes Canada Clinical Practice Guidelines Expert C, Mancini GBJ, Hegele RA, Leiter LA (2018) Dyslipidemia. Can J Diabetes 42(Suppl 1):S178\u2013S185. https:\/\/doi.org\/10.1016\/j.jcjd.2017.10.019","journal-title":"Can J Diabetes"},{"key":"4947_CR101","doi-asserted-by":"publisher","first-page":"Itc81","DOI":"10.7326\/aitc201712050","volume":"167","author":"L Kopin","year":"2017","unstructured":"Kopin L, Lowenstein C (2017) Dyslipidemia. Ann Intern Med 167:Itc81\u2013Itc96. https:\/\/doi.org\/10.7326\/aitc201712050","journal-title":"Ann Intern Med"},{"key":"4947_CR102","doi-asserted-by":"publisher","first-page":"115876","DOI":"10.1016\/j.bcp.2023.115876","volume":"218","author":"M Al Zein","year":"2023","unstructured":"Al Zein M, Zein O, Diab R, Dimachkie L, Sahebkar A, Al-Asmakh M, Kobeissy F, Eid AH (2023) Intermittent fasting favorably modulates adipokines and potentially attenuates atherosclerosis. Biochem Pharmacol 218:115876. https:\/\/doi.org\/10.1016\/j.bcp.2023.115876","journal-title":"Biochem Pharmacol"},{"key":"4947_CR103","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.tips.2018.09.005","volume":"39","author":"M Mohajeri","year":"2018","unstructured":"Mohajeri M, Banach M, Atkin SL, Butler AE, Ruscica M, Watts GF, Sahebkar A (2018) MicroRNAs: novel molecular targets and response modulators of statin therapy. Trends Pharmacol Sci 39:967\u2013981. https:\/\/doi.org\/10.1016\/j.tips.2018.09.005","journal-title":"Trends Pharmacol Sci"},{"key":"4947_CR104","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1161\/circresaha.118.313591","volume":"124","author":"D Wolf","year":"2019","unstructured":"Wolf D, Ley K (2019) Immunity and inflammation in atherosclerosis. Circ Res 124:315\u2013327. https:\/\/doi.org\/10.1161\/circresaha.118.313591","journal-title":"Circ Res"},{"key":"4947_CR105","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2147\/cia.S315837","volume":"16","author":"F Li","year":"2021","unstructured":"Li F, Li D, Yu J, Jia Y, Liu Y, Liu Y, Wu Q, Liao X, Zeng Z, Wan Z, Zeng R (2021) Silent myocardial infarction and long-term risk of frailty: the atherosclerosis risk in communities study. Clin Interv Aging 16:1139\u20131149. https:\/\/doi.org\/10.2147\/cia.S315837","journal-title":"Clin Interv Aging"},{"key":"4947_CR106","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.atherosclerosis.2012.01.020","volume":"222","author":"WJ Chen","year":"2012","unstructured":"Chen WJ, Yin K, Zhao GJ, Fu YC, Tang CK (2012) The magic and mystery of microRNA-27 in atherosclerosis. Atherosclerosis 222:314\u2013323. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.01.020","journal-title":"Atherosclerosis"},{"key":"4947_CR107","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.tcm.2019.01.001","volume":"29","author":"SO Almeida","year":"2019","unstructured":"Almeida SO, Budoff M (2019) Effect of statins on atherosclerotic plaque. Trends Cardiovasc Med 29:451\u2013455. https:\/\/doi.org\/10.1016\/j.tcm.2019.01.001","journal-title":"Trends Cardiovasc Med"},{"key":"4947_CR108","doi-asserted-by":"publisher","first-page":"673","DOI":"10.20945\/2359-3997000000292","volume":"64","author":"G Rissetti","year":"2021","unstructured":"Rissetti G, Zeni D, Ongaratti BR, Pereira-Lima JFS, Rech C, da Costa OM (2021) Lipid profile and response to statin therapy in patients with hypopituitarism. Arch Endocrinol Metab 64:673\u2013678. https:\/\/doi.org\/10.20945\/2359-3997000000292","journal-title":"Arch Endocrinol Metab"},{"key":"4947_CR109","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.phrs.2014.03.002","volume":"88","author":"CR Sirtori","year":"2014","unstructured":"Sirtori CR (2014) The pharmacology of statins. Pharmacol Res 88:3\u201311. https:\/\/doi.org\/10.1016\/j.phrs.2014.03.002","journal-title":"Pharmacol Res"},{"key":"4947_CR110","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1124\/jpet.117.242081","volume":"362","author":"SC Allen","year":"2017","unstructured":"Allen SC, Mamotte CDS (2017) Pleiotropic and adverse effects of statins-do epigenetics play a role? J Pharmacol Exp Ther 362:319\u2013326. https:\/\/doi.org\/10.1124\/jpet.117.242081","journal-title":"J Pharmacol Exp Ther"},{"key":"4947_CR111","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1080\/17425255.2020.1801634","volume":"16","author":"T Hirota","year":"2020","unstructured":"Hirota T, Fujita Y, Ieiri I (2020) An updated review of pharmacokinetic drug interactions and pharmacogenetics of statins. Expert Opin Drug Metab Toxicol 16:809\u2013822. https:\/\/doi.org\/10.1080\/17425255.2020.1801634","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"Suppl 1","key":"4947_CR112","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.amjcard.2020.12.018","volume":"144","author":"CG Santos-Gallego","year":"2021","unstructured":"Santos-Gallego CG, Badimon J (2021) Overview of aspirin and platelet biology. Am J Cardiol 144(Suppl 1):S2-s9. https:\/\/doi.org\/10.1016\/j.amjcard.2020.12.018","journal-title":"Am J Cardiol"},{"key":"4947_CR113","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10555-017-9675-z","volume":"36","author":"A Ornelas","year":"2017","unstructured":"Ornelas A, Zacharias-Millward N, Menter DG, Davis JS, Lichtenberger L, Hawke D, Hawk E, Vilar E, Bhattacharya P, Millward S (2017) Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention. Cancer Metastasis Rev 36:289\u2013303. https:\/\/doi.org\/10.1007\/s10555-017-9675-z","journal-title":"Cancer Metastasis Rev"},{"key":"4947_CR114","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3121\/cmr.2020.1548","volume":"18","author":"D Soodi","year":"2020","unstructured":"Soodi D, VanWormer JJ, Rezkalla SH (2020) Aspirin in primary prevention of cardiovascular events. Clin Med Res 18:89\u201394. https:\/\/doi.org\/10.3121\/cmr.2020.1548","journal-title":"Clin Med Res"},{"key":"4947_CR115","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.repc.2017.05.008","volume":"36","author":"AC Costa","year":"2017","unstructured":"Costa AC, Reina-Couto M, Albino-Teixeira A, Sousa T (2017) Aspirin and blood pressure: effects when used alone or in combination with antihypertensive drugs. Rev Port Cardiol 36:551\u2013567. https:\/\/doi.org\/10.1016\/j.repc.2017.05.008","journal-title":"Rev Port Cardiol"},{"key":"4947_CR116","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ijcard.2015.10.098","volume":"203","author":"MG Kok","year":"2016","unstructured":"Kok MG, Mandolini C, Moerland PD, de Ronde MW, Sondermeijer BM, Halliani A, Nieuwland R, Cipollone F, Creemers EE, Meijers JC, Pinto-Sietsma SJ (2016) Low miR-19b-1-5p expression in isolated platelets after aspirin use is related to aspirin insensitivity. Int J Cardiol 203:262\u2013263. https:\/\/doi.org\/10.1016\/j.ijcard.2015.10.098","journal-title":"Int J Cardiol"},{"key":"4947_CR117","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/13880209.2021.2007268","volume":"60","author":"Q Shen","year":"2022","unstructured":"Shen Q, Chen Q, Liu Y, Xue X, Shen X, He Q, Wang G, Han F (2022) Aspirin relieves the calcification of aortic smooth muscle cells by enhancing the heat shock response. Pharm Biol 60:17\u201324. https:\/\/doi.org\/10.1080\/13880209.2021.2007268","journal-title":"Pharm Biol"},{"key":"4947_CR118","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12967-016-0961-2","volume":"14","author":"X Guo","year":"2016","unstructured":"Guo X, Yu L, Chen M, Wu T, Peng X, Guo R, Zhang B (2016) miR-145 mediated the role of aspirin in resisting VSMCs proliferation and anti-inflammation through CD40. J Transl Med 14:211. https:\/\/doi.org\/10.1186\/s12967-016-0961-2","journal-title":"J Transl Med"},{"key":"4947_CR119","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1093\/eurheartj\/eht007","volume":"34","author":"HC de Boer","year":"2013","unstructured":"de Boer HC, van Solingen C, Prins J, Duijs JM, Huisman MV, Rabelink TJ, van Zonneveld AJ (2013) Aspirin treatment hampers the use of plasma microRNA-126 as a biomarker for the progression of vascular disease. Eur Heart J 34:3451\u20133457. https:\/\/doi.org\/10.1093\/eurheartj\/eht007","journal-title":"Eur Heart J"},{"key":"4947_CR120","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1161\/CIRCRESAHA.111.300539","volume":"112","author":"P Willeit","year":"2013","unstructured":"Willeit P, Zampetaki A, Dudek K, Kaudewitz D, King A, Kirkby NS, Crosby-Nwaobi R, Prokopi M, Drozdov I, Langley SR, Sivaprasad S, Markus HS, Mitchell JA, Warner TD, Kiechl S, Mayr M (2013) Circulating microRNAs as novel biomarkers for platelet activation. Circ Res 112:595\u2013600. https:\/\/doi.org\/10.1161\/CIRCRESAHA.111.300539","journal-title":"Circ Res"},{"key":"4947_CR121","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.freeradbiomed.2017.01.010","volume":"104","author":"J Kim","year":"2017","unstructured":"Kim J, Lee KS, Kim JH, Lee DK, Park M, Choi S, Park W, Kim S, Choi YK, Hwang JY, Choe J, Won MH, Jeoung D, Lee H, Ryoo S, Ha KS, Kwon YG, Kim YM (2017) Aspirin prevents TNF-alpha-induced endothelial cell dysfunction by regulating the NF-kappaB-dependent miR-155\/eNOS pathway: role of a miR-155\/eNOS axis in preeclampsia. Free Radic Biol Med 104:185\u2013198. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.01.010","journal-title":"Free Radic Biol Med"},{"key":"4947_CR122","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/s0140-6736(20)32335-7","volume":"398","author":"LC Chappell","year":"2021","unstructured":"Chappell LC, Cluver CA, Kingdom J, Tong S (2021) Pre-eclampsia. Lancet 398:341\u2013354. https:\/\/doi.org\/10.1016\/s0140-6736(20)32335-7","journal-title":"Lancet"},{"key":"4947_CR123","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1183\/09031936.06.00095705","volume":"27","author":"IM Robbins","year":"2006","unstructured":"Robbins IM, Kawut SM, Yung D, Reilly MP, Lloyd W, Cunningham G, Loscalzo J, Kimmel SE, Christman BW, Barst RJ (2006) A study of aspirin and clopidogrel in idiopathic pulmonary arterial hypertension. Eur Respir J 27:578\u2013584. https:\/\/doi.org\/10.1183\/09031936.06.00095705","journal-title":"Eur Respir J"},{"key":"4947_CR124","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/hypertensionaha.117.07802","volume":"70","author":"TJ Guzik","year":"2017","unstructured":"Guzik TJ, Touyz RM (2017) Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension 70:660\u2013667. https:\/\/doi.org\/10.1161\/hypertensionaha.117.07802","journal-title":"Hypertension"},{"key":"4947_CR125","doi-asserted-by":"publisher","first-page":"L413","DOI":"10.1152\/ajplung.00519.2020","volume":"320","author":"C Delaney","year":"2021","unstructured":"Delaney C, Davizon-Castillo P, Allawzi A, Posey J, Gandjeva A, Neeves K, Tuder RM, Di Paola J, Stenmark KR, Nozik ES (2021) Platelet activation contributes to hypoxia-induced inflammation. Am J Physiol Lung Cell Mol Physiol 320:L413-l421. https:\/\/doi.org\/10.1152\/ajplung.00519.2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"4947_CR126","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10557-013-6471-z","volume":"27","author":"LX Jia","year":"2013","unstructured":"Jia LX, Qi GM, Liu O, Li TT, Yang M, Cui W, Zhang WM, Qi YF, Du J (2013) Inhibition of platelet activation by clopidogrel prevents hypertension-induced cardiac inflammation and fibrosis. Cardiovasc Drugs Ther 27:521\u2013530. https:\/\/doi.org\/10.1007\/s10557-013-6471-z","journal-title":"Cardiovasc Drugs Ther"},{"key":"4947_CR127","doi-asserted-by":"publisher","first-page":"e007811","DOI":"10.1161\/circinterventions.119.007811","volume":"12","author":"NL Pereira","year":"2019","unstructured":"Pereira NL, Rihal CS, So DYF, Rosenberg Y, Lennon RJ, Mathew V, Goodman SG, Weinshilboum RM, Wang L, Baudhuin LM, Lerman A, Hasan A, Iturriaga E, Fu YP, Geller N, Bailey K, Farkouh ME (2019) Clopidogrel pharmacogenetics. Circ Cardiovasc Interv 12:e007811. https:\/\/doi.org\/10.1161\/circinterventions.119.007811","journal-title":"Circ Cardiovasc Interv"},{"key":"4947_CR128","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2147\/tcrm.S80437","volume":"11","author":"ZY Wang","year":"2015","unstructured":"Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q (2015) Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy. Ther Clin Risk Manag 11:449\u2013467. https:\/\/doi.org\/10.2147\/tcrm.S80437","journal-title":"Ther Clin Risk Manag"},{"key":"4947_CR129","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11906-011-0235-6","volume":"14","author":"S Batkai","year":"2012","unstructured":"Batkai S, Thum T (2012) MicroRNAs in hypertension: mechanisms and therapeutic targets. Curr Hypertens Rep 14:79\u201387. https:\/\/doi.org\/10.1007\/s11906-011-0235-6","journal-title":"Curr Hypertens Rep"},{"key":"4947_CR130","doi-asserted-by":"publisher","first-page":"e0196697","DOI":"10.1371\/journal.pone.0196697","volume":"13","author":"S Vandenwijngaert","year":"2018","unstructured":"Vandenwijngaert S, Ledsky CD, Agha O, Wu C, Hu D, Bagchi A, Domian IJ, Buys ES, Newton-Cheh C, Bloch DB (2018) MicroRNA-425 and microRNA-155 cooperatively regulate atrial natriuretic peptide expression and cGMP production. PLoS ONE 13:e0196697. https:\/\/doi.org\/10.1371\/journal.pone.0196697","journal-title":"PLoS ONE"},{"key":"4947_CR131","doi-asserted-by":"publisher","first-page":"496","DOI":"10.3390\/biom12040496","volume":"12","author":"J Xu","year":"2022","unstructured":"Xu J, Linneman J, Zhong Y, Yin H, Xia Q, Kang K, Gou D (2022) MicroRNAs in pulmonary hypertension, from pathogenesis to diagnosis and treatment. Biomolecules 12:496. https:\/\/doi.org\/10.3390\/biom12040496","journal-title":"Biomolecules"},{"key":"4947_CR132","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1164\/rccm.201106-1093oc","volume":"185","author":"SS Pullamsetti","year":"2012","unstructured":"Pullamsetti SS, Doebele C, Fischer A, Savai R, Kojonazarov B, Dahal BK, Ghofrani HA, Weissmann N, Grimminger F, Bonauer A, Seeger W, Zeiher AM, Dimmeler S, Schermuly RT (2012) Inhibition of MicroRNA-17 improves lung and heart function in experimental pulmonary hypertension. Am J Respir Crit Care Med 185:409\u2013419. https:\/\/doi.org\/10.1164\/rccm.201106-1093oc","journal-title":"Am J Respir Crit Care Med"},{"key":"4947_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/797898","volume":"2014","author":"CJ Guo","year":"2014","unstructured":"Guo CJ, Pan Q, Xiong H, Qiao YQ, Bian ZL, Zhong W, Sheng L, Li H, Shen L, Hua J, Ma X (2014) Therapeutic potential of MicroRNA: a new target to treat intrahepatic portal hypertension? Biomed Res Int 2014:1\u20138. https:\/\/doi.org\/10.1155\/2014\/797898","journal-title":"Biomed Res Int"},{"key":"4947_CR134","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","volume":"4","author":"YS Lee","year":"2009","unstructured":"Lee YS, Dutta A (2009) MicroRNAs in cancer. Annu Rev Pathol 4:199\u2013227. https:\/\/doi.org\/10.1146\/annurev.pathol.4.110807.092222","journal-title":"Annu Rev Pathol"},{"key":"4947_CR135","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.7150\/ijbs.47203","volume":"16","author":"B He","year":"2020","unstructured":"He B, Zhao Z, Cai Q, Zhang Y, Zhang P, Shi S, Xie H, Peng X, Yin W, Tao Y, Wang X (2020) miRNA-based biomarkers, therapies, and resistance in cancer. Int J Biol Sci 16:2628\u20132647. https:\/\/doi.org\/10.7150\/ijbs.47203","journal-title":"Int J Biol Sci"},{"key":"4947_CR136","doi-asserted-by":"publisher","first-page":"119005","DOI":"10.1016\/j.lfs.2020.119005","volume":"268","author":"S Mirzaei","year":"2021","unstructured":"Mirzaei S, Zarrabi A, Asnaf SE, Hashemi F, Zabolian A, Hushmandi K, Raei M, Goharrizi M, Makvandi P, Samarghandian S, Najafi M, Ashrafizadeh M, Aref AR, Hamblin MR (2021) The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators. Life Sci 268:119005. https:\/\/doi.org\/10.1016\/j.lfs.2020.119005","journal-title":"Life Sci"},{"key":"4947_CR137","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.critrevonc.2015.10.003","volume":"98","author":"S Mishra","year":"2016","unstructured":"Mishra S, Yadav T, Rani V (2016) Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol 98:12\u201323. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.10.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"4947_CR138","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/thno.11543","volume":"5","author":"G Bertoli","year":"2015","unstructured":"Bertoli G, Cava C, Castiglioni I (2015) MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics 5:1122\u20131143. https:\/\/doi.org\/10.7150\/thno.11543","journal-title":"Theranostics"},{"key":"4947_CR139","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1111\/jcmm.13450","volume":"22","author":"F Magri","year":"2018","unstructured":"Magri F, Vanoli F, Corti S (2018) miRNA in spinal muscular atrophy pathogenesis and therapy. J Cell Mol Med 22:755\u2013767. https:\/\/doi.org\/10.1111\/jcmm.13450","journal-title":"J Cell Mol Med"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-04947-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-024-04947-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-024-04947-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T07:37:10Z","timestamp":1729841830000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-024-04947-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,29]]},"references-count":139,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["4947"],"URL":"https:\/\/doi.org\/10.1007\/s11010-024-04947-9","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,29]]},"assertion":[{"value":"26 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}